Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/16 → 10/5/17 |
Funding
- Quintiles Inc: $54,132.00
Phase 3, Prospective, Randomized, Multi-Center Clinical Study Comparing the Safety and Efficacy of BAX855 Following PK Guided Prophylaxis Targeting Two Different FVIII Through Levels in Subjects with Severe Hemophilia A
- Radulescu, Vlad (PI)